GARAMYCIN
Pronunciation: jen-ta-MYE-sin

What it isAminoglycoside inhibiting the 30S ribosome; serious Gram-negative infection and combination therapy for endocarditis.
Why this oneAmong aminoglycosides, it is the standard partner for Gram-positive endocarditis synergy.
What limits itMonitor levels and renal function: nephrotoxicity is often reversible, but vestibular or auditory damage may not be.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Serious bacterial infection | Adults, normal renal function | 3 mg/kg/day divided q8h | 3 mg/kg/day q8h | 5 mg/kg/day (life-threatening; 3–4 divided doses) |
| Serious bacterial infection | Children | 6–7.5 mg/kg/day (2–2.5 mg/kg q8h) | ||
| Serious bacterial infection | Infants/neonates | 7.5 mg/kg/day (2.5 mg/kg q8h) | ||
| Serious bacterial infection | Neonates ≤1 wk / premature | 5 mg/kg/day (2.5 mg/kg q12h) |
Renal Reduce dose or extend dosing interval in renal impairment; monitor peak and trough serum levels
Hepatic Undefined
Available strengths
Pregnancy Aminoglycosides can cause fetal harm (see Warnings)
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 0.3 % | drops | per unit | not offered | |
| 1.2 mg/mL | inj | per unit | not offered | |
| 1.6 mg/mL | inj | per unit | not offered | |
| 2 mg/mL | inj | per unit | not offered | |
| 10 mg/mL | inj | per unit | not offered | |
| 40 mg/mL | inj | per unit | $1.30/mL | not offered |
Generic entryPre-1982
⚠ BOXED WARNINGS
Legacy pregnancy categoryD
Defining liabilityNephrotoxicity and often irreversible ototoxicity require renal and concentration monitoring.